Effects of Belimumab on Renal Outcomes, Overall SLE Control and Biomarkers: Findings from a Phase 3, Randomized, Placebo-controlled 104-week Study in Patients with Active Lupus Nephritis Richard Furie, MD – Northwell Health
11:45 AM – 12:00 PM ET
Denosumab versus Oral Bisphosphonate for Osteoporosis in Long-term Glucocorticoid Users: A 12-month Randomized Controlled Trial Chi Chiu Mok, MD – Tuen Mun Hospital
12:00 PM – 12:15 PM ET
High-dimensional Analyses of Checkpoint-inhibitor Related Arthritis Synovial Fluid Cells Reveal a Unique, Proliferating CD38hi Cytotoxic CD8 T Cell Population Induced by Type I IFN Runci Wang, MD, PhD – Brigham and women's hospital
12:15 PM – 12:30 PM ET
Cluster-randomized Pragmatic Clinical Trial Evaluating the Potential Benefit of a Tight-control and Treat-to-target Strategy in Axial Spondyloarthritis: The Results of the TICOSPA Trial Anna Molto, MD – Rheumatology department, Cochin hospital, APHP, Paris
12:30 PM – 12:45 PM ET
Citrulline Reactive B Cells Are Present in the Lungs of Risk RA and Early Untreated RA Vijay Joshua, PhD – Karolinska Institutet
12:45 PM – 1:00 PM ET
Pregnancy Outcomes in Patients with Interstitial Lung Disease Aardra Rajendran, BSc – Duke University School of Medicine
.png "Gregg Silverman, MD photo")
.png "Diane Kamen, MD, MSCR photo")
